Age and aging in blood disorders: multiple myeloma

av Zweegman, Sonja, Palumbo, Antonio, Bringhen, Sara, Sonneveld, Pieter
Publicerad 2014

Carfilzomib combination treatment as first-line therapy in multiple myeloma: where do we go from the Carthadex (KTd)-trial update?

av Engelhardt, Monika, Yong, Kwee, Bringhen, Sara, Wäsch, Ralph
I publikationen Haematologica (2019)

Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True

av Mattia D’Agostino, Salvatore Innorcia, Mario Boccadoro, Sara Bringhen
Publicerad 2020-11-01

Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True

av D’Agostino, Mattia, Innorcia, Salvatore, Boccadoro, Mario, Bringhen, Sara
I publikationen Int J Mol Sci (2020)

Emerging drugs and combinations to treat multiple myeloma

av Larocca, Alessandra, Mina, Roberto, Gay, Francesca, Bringhen, Sara, Boccadoro, Mario
I publikationen Oncotarget (2017)

Approach to the Older Adult With Multiple Myeloma

av Mina, Roberto, Bringhen, Sara, Wildes, Tanya M., Zweegman, Sonja, Rosko, Ashley E.
I publikationen Am Soc Clin Oncol Educ Book (2019)

The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma

av Bonello, Francesca, Grasso, Mariella, D’Agostino, Mattia, Celeghini, Ivana, Castellino, Alessia, Boccadoro, Mario, Bringhen, Sara
I publikationen Pharmaceuticals (Basel) (2020)

Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma

av Mateos, María-Victoria, Bladé, Joan, Bringhen, Sara, Ocio, Enrique M, Efebera, Yvonne, Pour, Luděk, Gay, Francesca, Sonneveld, Pieter, Gullbo, Joachim, Richardson, Paul G.
I publikationen J Clin Med (2020)

Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy

av Bruno, Giulia, Bringhen, Sara, Maffei, Ilaria, Iannaccone, Andrea, Crea, Teresa, Ravera, Agnese, Astarita, Anna, Vallelonga, Fabrizio, Salvini, Marco, Gay, Francesca, Veglio, Franco, Milan, Alberto
I publikationen Cancers (Basel) (2019)

P24: EXPERT PERSPECTIVES OF UNMET NEED IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE LENALIDOMIDE-SPARING REGIMENS IN EUROPE

av M Mateos, X Leleu, E Zamagni, M Delforge, S Bringhen, A Broijl, J de la Rubia, A Shaw, A Brescianini, S Gonzalez-McQuire, S Patel, P Moreau
Publicerad 2022-04-01

Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long‐term survival follow‐up from the Phase II study O‐12‐M1

av Bringhen, Sara, Voorhees, Peter M., Plesner, Torben, Mellqvist, Ulf‐Henrik, Reeves, Brandi, Sonneveld, Pieter, Byrne, Catriona, Nordström, Eva, Harmenberg, Johan, Obermüller, Jakob, Richardson, Paul G.
I publikationen Br J Haematol (2021)

Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma

av Mian, Hira, Grant, Shakira J., Engelhardt, Monika, Pawlyn, Charlotte, Bringhen, Sara, Zweegman, Sonja, Stege, Claudia A.M., Rosko, Ashley E., von Lilienfeld-Toal, Marie, Wildes, Tanya M.
I publikationen J Geriatr Oncol (2020)

Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies

av Caltagirone, Simona, Ruggeri, Marina, Aschero, Simona, Gilestro, Milena, Oddolo, Daniela, Gay, Francesca, Bringhen, Sara, Musolino, Caterina, Baldini, Luca, Musto, Pellegrino, Petrucci, Maria T., Gaidano, Gianluca, Passera, Roberto, Bruno, Benedetto, Palumbo, Antonio, Boccadoro, Mario, Omedè, Paola
Publicerad 2014

Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction

av Astarita, Anna, Mingrone, Giulia, Airale, Lorenzo, Vallelonga, Fabrizio, Covella, Michele, Catarinella, Cinzia, Cesareo, Marco, Bruno, Giulia, Leone, Dario, Giordana, Carlo, Cetani, Giusy, Salvini, Marco, Gay, Francesca, Bringhen, Sara, Rabbia, Franco, Veglio, Franco, Milan, Alberto
I publikationen Cancers (Basel) (2021)

Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients

av Mingrone, Giulia, Astarita, Anna, Airale, Lorenzo, Maffei, Ilaria, Cesareo, Marco, Crea, Teresa, Bruno, Giulia, Leone, Dario, Avenatti, Eleonora, Catarinella, Cinzia, Salvini, Marco, Cetani, Giusy, Gay, Francesca, Bringhen, Sara, Veglio, Franco, Vallelonga, Fabrizio, Milan, Alberto
I publikationen Front Cardiovasc Med (2021)

Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial

av Palumbo, Antonio, Larocca, Alessandra, Genuardi, Mariella, Kotwica, Katarzyna, Gay, Francesca, Rossi, Davide, Benevolo, Giulia, Magarotto, Valeria, Cavallo, Federica, Bringhen, Sara, Rus, Cecilia, Masini, Luciano, Iacobelli, Massimo, Gaidano, Gianluca, Mitsiades, Constantine, Anderson, Kenneth, Boccadoro, Mario, Richardson, Paul
Publicerad 2010

Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multiple myeloma

av Dimopoulos, Meletios, Bringhen, Sara, Anttila, Pekka, Capra, Marcelo, Cavo, Michele, Cole, Craig, Gasparetto, Cristina, Hungria, Vania, Jenner, Matthew, Vorobyev, Vladimir, Ruiz, Eduardo Yanez, Yin, Jian Y., Saleem, Rao, Hellet, Maeva, Macé, Sandrine, Paiva, Bruno, Vij, Ravi
I publikationen Blood (2021)

Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis

av Schjesvold, Fredrik, Richardson, Paul G., Facon, Thierry, Alegre, Adrián, Spencer, Andrew, Jurczyszyn, Artur, Sunami, Kazutaka, Frenzel, Laurent, Min, Chang-Ki, Guillonneau, Sophie, Lin, Peggy L., Le-Guennec, Solenn, Campana, Frank, van de Velde, Helgi, Bensfia, Samira, Bringhen, Sara
I publikationen Haematologica (2021)

Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma

av Facon, Thierry, Niesvizky, Ruben, Mateos, Maria-Victoria, Siegel, David, Rosenbaum, Cara, Bringhen, Sara, Weisel, Katja, Ho, P. Joy, Ludwig, Heinz, Kumar, Shaji, Wang, Kenneth, Obreja, Mihaela, Yang, Zhao, Klippel, Zandra, Mezzi, Khalid, Goldrick, Amanda, Tekle, Christina, Dimopoulos, Meletios A.
I publikationen Blood Adv (2020)

Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-do...

av Mateos, María-Victoria, Bringhen, Sara, Richardson, Paul G., Lahuerta, Juan Jose, Larocca, Alessandra, Oriol, Albert, Boccadoro, Mario, García-Sanz, Ramón, Di Raimondo, Francesco, Esseltine, Dixie-Lee, van de Velde, Helgi, Desai, Avinash, Londhe, Anil, San Miguel, Jesús F., Palumbo, Antonio
Publicerad 2014